Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774071/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer
by: Elmer Joel Millan-Casarrubias, et al.
Published: (2025-03-01) -
HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy
by: Qiangzu Shao, et al.
Published: (2025-03-01) -
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
by: Lucía Gandullo‐Sánchez, et al.
Published: (2020-04-01) -
Target therapy in treatment of HER2-positive breast cancer
by: A. S. Belokhvostova, et al.
Published: (2016-02-01) -
Nanoliposome-encapsulated MAGE peptides: A promising melanoma vaccine to activate human dendritic cells
by: Azin Bavafa, et al.
Published: (2025-05-01)